GPHL on March 12th appointed Randy Schekman, the 2013 Nobel Laureate in Physiology or Medicine, as the chief scientist of both the group and its subsidiary Guangzhou General Pharmaceutical Research In
GPHL’s Chairman Li Chuyuan, a member of the Guangzhou delegation, attended the Annual Meeting of the New Champions 2019, also known as the Summer Davos Forum in Dalian between July 1st and 3rd.
From June 24th to 27th, GPHL’s roxburgh rose products are exhibited at the 16th China International Small and Medium Enterprises Fair (CISMEF) in Guangzhou.
Artemisinin to remain main anti-malaria drug is the important fruition of TCM’s modernization. As regarding to the modernization and promotion of TCM, GPHL has also been making great efforts.
GPHL’s roxburgh rose products were officially launched on June 5th, after a ceremony held in the Guizhou Garden at the International Horticultural Exhibition 2019 in Beijing.
Over 500 overseas news agencies from about 40 countries and regions have given extensive coverage to GPHL’s moves in New Zealand, including Business Insider, NBC, CBS and TASS.
The Tripartite 2019 meeting among Auckland, New Zealand, Guangzhou, China and Los Angeles, the United States, was launched on Monday to promote trade and innovation cooperatio.
Recently, GPHL’s Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co., Ltd. won two first prizes for its two Quality Control (QC) achievements at a conference held by Guangdong Association for Quality.
On May 18th, a delegation from Guangzhou municipality, including representatives from GPHL, headed to Auckland for the Tripartite Economic Alliance Summit 2019.
On May 20th, GPHL and the Confucius Institute in Auckland (“CI in Auckland”) announced a TCM promotion partnership.
GPHL signed an agreement on Monday with the Confucius Institute in Auckland, New Zealand to build the Shennong Caotang TCM Culture Communication Center.
GPHL’s business performance remained steady with fast growth in the first quarter of 2019.Its profit growth has exceeded the industry average,and the organisation is leading the market.